ステロイドホルモン受容体スーパーファミリーのコアクティベーターの配列と特徴づけ
まとめ
研究者らは,ヒトのプロゲステロン受容体 (hPR) の活性を増強するタンパク質であるステロイド受容体協活性化剤-1 (SRC-1) を特定した. SRC-1は,ステロイド受容体スーパーファミリー全体の転写機能に不可欠です.
科学分野:
- 分子生物学は分子生物学である.
- エンドクリノロジー エンドクリノロジー
- 遺伝学 遺伝学とは
背景:
- ステロイド受容体は遺伝子発現を調節する.
- コアクティベーターの理解は,転写調節の解読の鍵です.
研究 の 目的:
- 人間のプロゲステロン受容体 (hPR) と相互作用するタンパク質を特定する.
- ステロイド受容体の活性における特定されたタンパク質の機能を特徴づける.
主な方法:
- タンパク質相互作用スクリーニングのための酵母2ハイブリッドシステム.
- レポーター遺伝子解析は,転写活動の測定を目的としています.
- 支配的な負の効果を評価するために,断片化されたSRC-1の発現.
主要な成果:
- 新しいタンパク質であるステロイド受容体協活性化剤-1 (SRC-1) が特定されました.
- SRC-1は,基礎プロモーターの活性に影響を与えることなく,hPRの転写活動を強化します.
- SRC-1は複数のステロイド受容体のトランザクティベーションを刺激する.
- SRC-1は,エストロゲン受容体媒介によるhPR活性抑制を逆転させます.
- 断絶されたSRC-1変異体では,支配的陰性抑制機能が観察されました.
結論:
- SRC-1はステロイド受容体の完全な転写活動に不可欠な共同活性化剤です.
- SRC-1は,ステロイドホルモンシグナル伝達経路において重要な役割を果たしています.
- この発見は,ステロイド受容体媒介遺伝子調節のメカニズムについての洞察を提供します.
さらに関連する動画
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 16, 2013
09:07Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
関連する概念動画
Cooperative Binding of Transcription Regulators
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Cooperative Binding of Transcription Regulators
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
